DK1144000T3 - Ny fremgangsmåde til dialyse - Google Patents

Ny fremgangsmåde til dialyse

Info

Publication number
DK1144000T3
DK1144000T3 DK00901367T DK00901367T DK1144000T3 DK 1144000 T3 DK1144000 T3 DK 1144000T3 DK 00901367 T DK00901367 T DK 00901367T DK 00901367 T DK00901367 T DK 00901367T DK 1144000 T3 DK1144000 T3 DK 1144000T3
Authority
DK
Denmark
Prior art keywords
dialysis
new method
treatment
molecular weight
low molecular
Prior art date
Application number
DK00901367T
Other languages
Danish (da)
English (en)
Inventor
Gunnar Fager
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1144000T3 publication Critical patent/DK1144000T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3427—Substitution fluid path back through the membrane, e.g. by inverted trans-membrane pressure [TMP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
DK00901367T 1999-01-11 2000-01-11 Ny fremgangsmåde til dialyse DK1144000T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900043A SE9900043D0 (sv) 1999-01-11 1999-01-11 New use

Publications (1)

Publication Number Publication Date
DK1144000T3 true DK1144000T3 (da) 2006-05-08

Family

ID=20414050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00901367T DK1144000T3 (da) 1999-01-11 2000-01-11 Ny fremgangsmåde til dialyse

Country Status (19)

Country Link
US (4) US20030042202A1 (zh)
EP (1) EP1144000B1 (zh)
JP (1) JP4054533B2 (zh)
KR (1) KR100840452B1 (zh)
CN (1) CN100387296C (zh)
AT (1) ATE316384T1 (zh)
AU (1) AU763185B2 (zh)
BR (1) BR0007448A (zh)
CA (1) CA2356440A1 (zh)
CY (1) CY1107461T1 (zh)
DE (1) DE60025698T2 (zh)
DK (1) DK1144000T3 (zh)
ES (1) ES2255968T3 (zh)
IL (1) IL143824A0 (zh)
NO (1) NO326996B1 (zh)
NZ (1) NZ512712A (zh)
SE (1) SE9900043D0 (zh)
WO (1) WO2000041715A1 (zh)
ZA (1) ZA200105274B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112572B2 (en) 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
MXPA05002661A (es) 2002-09-09 2005-08-19 Trigen Ltd Sales de acido boronico y su uso en el tratamiento de trombosis.
US7235589B2 (en) * 2004-09-21 2007-06-26 Bio Numerik Pharmaceuticals, Inc. Method of treating patients undergoing kidney dialysis
CA3241457A1 (en) 2005-12-21 2008-05-15 Meso Scale Technologies, Llc Assay apparatuses, methods and reagents
CN105115949B (zh) * 2005-12-21 2018-06-22 梅索斯卡莱科技公司 分析装置、方法和试剂
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
CN103889481B (zh) * 2011-08-02 2016-03-09 美敦力公司 带有具有可控的顺应性容积的流动路径的血液透析系统
US10850016B2 (en) 2013-02-01 2020-12-01 Medtronic, Inc. Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection
US9623164B2 (en) 2013-02-01 2017-04-18 Medtronic, Inc. Systems and methods for multifunctional volumetric fluid control
US10010663B2 (en) 2013-02-01 2018-07-03 Medtronic, Inc. Fluid circuit for delivery of renal replacement therapies
US10098993B2 (en) 2014-12-10 2018-10-16 Medtronic, Inc. Sensing and storage system for fluid balance
US9713665B2 (en) 2014-12-10 2017-07-25 Medtronic, Inc. Degassing system for dialysis
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
US11278654B2 (en) 2017-12-07 2022-03-22 Medtronic, Inc. Pneumatic manifold for a dialysis system
US11033667B2 (en) 2018-02-02 2021-06-15 Medtronic, Inc. Sorbent manifold for a dialysis system
US11110215B2 (en) 2018-02-23 2021-09-07 Medtronic, Inc. Degasser and vent manifolds for dialysis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
EA002767B1 (ru) * 1995-02-10 2002-08-29 Басф Акциенгезельшафт Ингибиторы тромбина
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
CZ291690B6 (cs) * 1996-02-13 2003-05-14 Akzo Nobel N. V. Inhibitory serinové proteázy a farmaceutický prostředek
EP0884325A1 (en) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
DE69828522T2 (de) * 1997-04-30 2005-12-15 Eli Lilly And Co., Indianapolis Antithrombotische mittel
WO1998048800A1 (en) * 1997-05-01 1998-11-05 Eli Lilly And Company Antithrombotic agents
CA2287569A1 (en) * 1997-05-02 1998-11-12 Akzo Nobel Nv Serine protease inhibitors

Also Published As

Publication number Publication date
US20090192137A1 (en) 2009-07-30
EP1144000A1 (en) 2001-10-17
NZ512712A (en) 2004-09-24
ATE316384T1 (de) 2006-02-15
BR0007448A (pt) 2001-10-16
IL143824A0 (en) 2002-04-21
CY1107461T1 (el) 2012-12-19
US20080004225A1 (en) 2008-01-03
KR100840452B1 (ko) 2008-06-20
CN100387296C (zh) 2008-05-14
CN1354673A (zh) 2002-06-19
ES2255968T3 (es) 2006-07-16
WO2000041715A1 (en) 2000-07-20
NO20013301L (no) 2001-07-03
JP4054533B2 (ja) 2008-02-27
SE9900043D0 (sv) 1999-01-11
NO326996B1 (no) 2009-03-30
JP2002534217A (ja) 2002-10-15
NO20013301D0 (no) 2001-07-03
ZA200105274B (en) 2002-09-26
KR20010093250A (ko) 2001-10-27
AU763185B2 (en) 2003-07-17
EP1144000B1 (en) 2006-01-25
CA2356440A1 (en) 2000-07-20
DE60025698D1 (de) 2006-04-13
AU2140900A (en) 2000-08-01
US20050153904A1 (en) 2005-07-14
US20030042202A1 (en) 2003-03-06
DE60025698T2 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
CY1107461T1 (el) Νεα μεθοδος διαπιδυσης
AR042795A1 (es) Fluidos de dialisis biocompatibles que contienen icodextrinas
SE0103907D0 (sv) Method of operating a dialysis machine
DK0652780T3 (da) Apparat og fremgangsmåde til forebyggelse af hypotension hos dialysepatienter
DE69736605D1 (de) Verwendung von taurolidine oder taurultam zur behandlung und prävention von infektionen in medizinischen freisetzungssystemen
YU16902A (sh) Farmaceutski rastvori levosimendana
DE60039978D1 (de) Substitutions-infusionflüssigkeit und zitratanticoagulation
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE311180T1 (de) Verfahren und pharmazeutische zusammensetzung zur verabreichung von eisen an hämodialyse- oder peritonealdialyse-patienten
EP1847527A4 (en) NEW BENZAMIDINE DERIVATIVE
SE9902597D0 (sv) New use
MX2007003120A (es) Metodo y composicion para el tratamiento de pacientes que se someten a dialisis de rinon.
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av
SE0301577L (sv) Lösning med låg natriumhalt
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
DE60117762D1 (de) Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
GB0007239D0 (en) Use
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
UA3797U (uk) Спосіб лікування тяжких проникаючих поранень ока
NO20043774L (no) The use of devazenide as analgesic agent
AU2001248355A1 (en) The use of anticoagulant agents in the extracorporeal treatment of blood
UA42404A (uk) Спосіб детоксикації організму